The present study shows that the combination of tumor and chemotherapy (C26 OXFU) leads to increased protein carbonylation that was associated with enhanced G6PD activity, likely due to an adaptive, though unsuccessful, response of the muscle to face the redox imbalance. Here, G6PD is linked to neoplasm.